6 | Proteins (Proteins, Gene)FDA Link
02/2018
-
02/2008 |
4 | SurvivinIBA
02/2018
-
01/2012 |
3 | Biomarkers (Surrogate Marker)IBA
12/2020
-
04/2016 |
3 | ErbB Receptors (EGF Receptor)IBA
01/2020
-
01/2012 |
3 | Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2016
-
11/2008 |
3 | sepantroniumIBA
04/2015
-
01/2012 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
06/2010
-
11/2009 |
2 | Cetuximab (Erbitux)FDA Link
11/2023
-
01/2016 |
2 | Sodium-Coupled Vitamin C TransportersIBA
01/2021
-
01/2016 |
2 | Inhibitor of Apoptosis ProteinsIBA
12/2020
-
09/2015 |
2 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
-
04/2016 |
2 | Sulindac (Copal)FDA LinkGeneric
09/2016
-
07/2009 |
2 | Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2016
-
07/2009 |
2 | GemcitabineFDA Link
04/2016
-
05/2012 |
2 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2015
-
06/2014 |
2 | Caspase 3 (Caspase-3)IBA
11/2015
-
05/2014 |
2 | Phosphotransferases (Kinase)IBA
07/2012
-
06/2010 |
2 | Ethanol (Ethyl Alcohol)IBA
01/2012
-
03/2011 |
1 | Monoclonal AntibodiesIBA
01/2024 |
1 | Immune Checkpoint InhibitorsIBA
01/2024 |
1 | Complement System Proteins (Complement)IBA
01/2024 |
1 | RON proteinIBA
11/2023 |
1 | Protein Isoforms (Isoforms)IBA
11/2023 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2023 |
1 | Janus Kinase InhibitorsIBA
01/2022 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2021 |
1 | CaspasesIBA
12/2020 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020 |
1 | MicroRNAs (MicroRNA)IBA
10/2020 |
1 | Tyrosine Kinase InhibitorsIBA
01/2020 |
1 | CateninsIBA
01/2019 |
1 | Mitogen-Activated Protein KinasesIBA
01/2019 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 |
1 | navitoclaxIBA
02/2018 |
1 | Histone Deacetylase InhibitorsIBA
04/2016 |
1 | Cadherins (E-Cadherin)IBA
04/2016 |
1 | AZD4547IBA
11/2015 |
1 | 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
11/2015 |
1 | Proto-Oncogene Proteins c-metIBA
11/2015 |
1 | N,N'- (2,2'- (hexa- 2,4- diyne- 1,6- diylbis(oxy))bis(2,3- dihydro- 1H- indene- 2,1- diyl))bis(1- (2- cyclohexyl- 2- (2- (methylamino)propanamido)acetyl)pyrrolidine- 2- carboxamide)IBA
09/2015 |
1 | Therapeutic UsesIBA
09/2015 |
1 | Baculoviral IAP Repeat-Containing 3 ProteinIBA
04/2015 |
1 | NPS-1034IBA
06/2014 |
1 | dactolisibIBA
05/2014 |
1 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2012 |
1 | Cell Cycle ProteinsIBA
07/2012 |
1 | Proteasome InhibitorsIBA
07/2012 |
1 | Bortezomib (Velcade)FDA Link
07/2012 |
1 | Apoptosis Regulatory ProteinsIBA
01/2012 |
1 | Trypan BlueFDA Link
01/2012 |
1 | Plant ExtractsIBA
03/2011 |
1 | bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
03/2011 |
1 | Etoposide (VP 16)FDA LinkGeneric
03/2010 |
1 | Forkhead Transcription Factors (Forkhead Box Proteins)IBA
03/2010 |
1 | Protein Kinase C-deltaIBA
11/2009 |
1 | p38 Mitogen-Activated Protein KinasesIBA
07/2009 |
1 | Cyclin-Dependent Kinase 4IBA
02/2009 |
1 | X-Linked Inhibitor of Apoptosis ProteinIBA
02/2009 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
11/2008 |